跳至主要内容
临床试验/CTRI/2020/03/023953
CTRI/2020/03/023953尚未招募2 期

Comaparative Effectivness of Lacosamide and Pregabalin in patients diagnosed with Neuropathic Pain : A Randomized, Controlled, Open Label Trial.

SRM College of Pharmacy0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients with definite or probable neuropathic pain for more than 3 months.
  • Patients who are willing to give informed consent

排除标准

  • Patient with concomitant pain syndrome that could affect the pain evaluation such fibromyalgia.
  • Patients with serious concurrent systemic disease such as liver problems, severe renal impairment, malignancy.
  • Patients with a history of cardiac arrhythmias or taking antiarrhythmic drugs
  • Patients with a resting heart rate of less than 55 beats/min or greater than 100 beats/min on electrocardiogram (ECG) screening
  • Patients on concomitant treatment with antidepressants, other anticonvulsants and opioids that could not be discontinued.
  • Pregnant women and lactating mothers.
  • Drug-induced neuropathic pain.
  • Patients who are not willing to give informed consent.

研究者

发起方
SRM College of Pharmacy

相似试验